How to buy Brickell Biotech stock (BBI)

Brickell Biotech is a biotechnology & medical research business based in the US. Brickell Biotech shares (BBI) are listed on the NASDAQ and all prices are listed in US Dollars. Brickell Biotech employs 16 staff and has a trailing 12-month revenue of around $4.6 million.

Our top picks for where to buy Brickell Biotech stock

Buy Brickell Biotech stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Brickell Biotech stock price (NASDAQ: BBI)

Use our graph to track the performance of BBI stocks over time.

Brickell Biotech shares at a glance

• Key figures

Information last updated 2024-06-09.

52-week range	$0.86 - $1.01
50-day moving average more info button	$3.00
200-day moving average more info button	$8.13
Wall St. target price	$17.83
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-0.42

Is it a good time to buy Brickell Biotech stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Brickell Biotech financials

Revenue TTM	$4.6 million
Gross profit TTM	$-27,827,000
Return on assets TTM	-80.2%
Return on equity TTM	-157.29%
Profit margin	0%
Book value	$5.81
Market Capitalization more info button	$6.8 million

TTM: trailing 12 months

Brickell Biotech share dividends

We're not expecting Brickell Biotech to pay a dividend over the next 12 months.

Have Brickell Biotech's shares ever split?

Brickell Biotech's shares were split on a 1:45 basis on 4 July 2022 . So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Brickell Biotech shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Brickell Biotech shares which in turn could have impacted Brickell Biotech's share price.

Brickell Biotech share price volatility

Over the last 12 months, Brickell Biotech's shares have ranged in value from as little as $0.86 up to $1.01. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Brickell Biotech's is 0.0796. This would suggest that Brickell Biotech's shares are less volatile than average (for this exchange).

Brickell Biotech overview

Brickell Biotech, Inc. , a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc. , Voronoi Inc. , Bodor Laboratories, Inc. and Dr.

Frequently asked questions

null
What percentage of Brickell Biotech is owned by insiders or institutions?
Currently 1.21% of Brickell Biotech shares are held by insiders and 13.075% by institutions. How many people work for Brickell Biotech?
Latest data suggests 16 work at Brickell Biotech. When does the fiscal year end for Brickell Biotech?
Brickell Biotech's fiscal year ends in December. Where is Brickell Biotech based?
Brickell Biotech's address is: 5777 Central Avenue, Boulder, CO, United States, 80301 What is Brickell Biotech's ISIN number?
Brickell Biotech's international securities identification number is: US10802T1051 What is Brickell Biotech's CUSIP number?
Brickell Biotech's Committee on Uniform Securities Identification Procedures number is: 10802T105